EXTRUSOR Tornillo Tornillo de regulación de rosca profunda de 1" a 6" Relación de compresión 3:1 Cabezal De tubo: sin hilera (para tamaños pequeños) De presión: para tamaños de 1" o superiores Dado De tubo: bajo coeficiente de estirado De presión: hilera corta L/D 24:1 o superior Paquete de mallas Malla de 20/40/20 Canal de enfriamiento 50–65°C recomendado Secador Aire caliente o desecante, 4 horas a 79–85°C PROCESAMIENTO Temperatura Precalentamiento del alambre Ninguno Zonas de alimentación 143–149°C Transición 160–171°C Dosificación 171–176°C Cabezal/dado 176–185°C Material fundido 176–185°C Fusión máxima 199°C Compuesto de purga HDPE www.avient.com Copyright © 2020, Avient Corporation.

VersaflexTM PF Versaflex PF VOC VERSAFLEX PF VOC 39 LDPE / 13 Versaflex PF VERSAFLEX PF 39 LDPE / 13 Versaflex PF N /2 5 N /2 5 F = 25 ° C 7 I = 25 ° C 20 MD6741 / MD6700 VERSAFLEX PFTM +86 021 60284888 www.avient.com VERSAFLEX™ PF 1 CF6751 PP 2 2420K LDPE Versaflex™ PF MD6727 Versaflex™ PF MD6741 Versaflex™ CF 6751 Versaflex™ PF MD6649 Versaflex™ PF 9512 Versaflex™ CF 8888N-A Versaflex™ PF MD6666 Versaflex™ PF MD6748 Versaflex™ PF MD6700 Versaflex™ CF 9000 PP PVC Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 / (Shore A) 50 49 35 37 38 35 37 31 30 19 MFI (190°C, 2.16kg) (g/10min) / / / 15 5 15 20 3 5 27 MFI (230°C, 2.16kg) 8 20 8 / / / / / / / 1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um (N/25mm) 25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3 75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 / PMMA (N/25mm) 25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9 75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /

% Solids Color Index pH Typical Weight Lbs/Gal WHITE 10WDN03 Titanium Dioxide, Rutile 60 73 PW-6 9 16.7 YELLOW 12WDN01 Diarylide AAOT GS 35 43 PY-14 8.8 9.4 12WDN02 Diarylide HR RS 37 44 PY-83 8.8 9.6 12WDN03 Arylide GY RS 38 45 PY-74 8.8 9.2 81WDN01 Iron Oxide 55 63 PY-42 8.8 14.5 ORANGE 15WDN01 Pryazolone YS 40 45 PO-13 8.8 9.2 15WDN03 Dianisidine RS 35 37 PO-16 8.8 9.2 15WDN06 DNA Orange RS 31 43 PO-5 8.8 9.7 RED 22WDN01 Lithol Rubine BS 33 40 PR-57 8.8 9.8 21WDN01 Naphthol BS 35 43 N/A 8.8 9.5 25WDN01 Red 2B, Ca BS 34 41 PR-48:2 8.8 9.6 28WDN01 Red 2B, Ba YS 36 44 PR-48:1 8.8 9.5 82WDN02 Iron Oxide 57 66 PR-101 8.8 16 BLUE 40WDN01 Phthalocyanine RS 35 46 PB-15 8.8 9.7 40WDN03 Phthalocyanine GS 38 43 PB-15:3 8.8 9.8 GREEN WDN-27822 Phthalocyanine BS 42 53 PG-7 8.8 10.5 VIOLET/MAGENTA 24WDN02 Carbazole 35 48 PV-23 8.8 9.6 24WDN03 Quinacridone 31 39 PV-19 8.8 9.6 24WDN05 Quinacridone 30 41 PR-122 8.8 10 BLACK 90WDN01 Carbon Black 45 49 PB-7 8.8 9.3 WDN RS = Red Shade YS = Yellow Shade BS = Blue Shade GS = Green Shade HR = Heat-Resistant www.avient.com Copyright © 2020, Avient Corporation.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Standard concentrates in a PE carrier and on request in PP • Pre-colored formulations can be supplied in specific resins selected for the application REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN DRUG TYPE COLOR DESCRIPTION PANTONE REFERENCE AVIENT PRODUCT CODE PE BASED Adrenergic agonist combinations Light Green 373 C PE6M176349 Adrenergic agonists Purple 2583 C PE4M176057 Anti-infectives Tan 467 C PE8M176130 Anti-inflammatory, nonsteroidal Grey Cool Grey 4 C PE7M176184 steroids Pink 197 C PE3M176237 Anti-inflammatory, immunomodulators Olive Green 5763 C On request Beta-blockers Yellow Yellow C PE1M176160 Beta-blocker combinations Dark Blue 281 C PE5M176272 Carbonic anhydrase inhibitors Orange 1585 C PE2M176089 Cytotoxic Black 6 C PL9M176008 Miotics Dark Green 348 C PE6M176267 Mydriatics and cycloplegics Red 1797 C PE3M176236 Prostaglandin analogues Turquoise 326 C PE5M176273 Healthcare use limitations apply—see below.

Änderungsbeschluss: Sonderband Blatt 101 ff. 2 b) Ximena, Philippe, Lyon (Frankreich), *18.11.1960 Setzen, Marc, Baden-Baden, *27.05.1969 05.02.2007 Seite 2 von 4 3 b) Adolf-Dambach-Str. 2, 76571 Gaggenau Tomaselli, Frank, La Wantzenau/Frankreich, *28.12.1963 Ximena, Philippe, Lyon (Frankreich), *18.11.1960 23.04.2009 4 b) Mohn, Christopher, Lasne/Belgien, *11.06.1955 10.01.2011 5 b) Neue Adolf-Dambach-Str.4, 76571 Gaggenau Kronimus, Holger, Hilgert, *26.01.1968 Baert, Bernard, Verviers/Belgien, *18.12.1949 Tomaselli, Frank, La Wantzenau/Frankreich, *28.12.1963 15.02.2012 6 b) Der zwischen der Gesellschaft und der nunmehr infolge Firmenänderung und Sitzverlegung "PolyOne Deutschland GmbH", Bendorf (Amtsgericht Koblenz HRB 7522) am 03.11.2014 Seite 3 von 4 13.12.1994 abgeschlossene Beherrschungs- und Ergebnisabführungsvertrag wurde neugefasst und besteht nunmehr als Gewinnabführungsvertrag fort.Die Gesellschafterversammlungen haben der Neufassung am 20.10.2014 zugestimmt.

6 Are you able to provide geolocation data for your facilities? They can be customized for specific needs and process efficiently with similar shrink rates to nylons. They then set up 4 bins in production to sort our plastic scrap into bins of PE/PP, PS, Nylon, and High Temp materials.

Common examples are polypropylene (PP), nylon (PA), polyketone (PK), and thermoplastic elastomers (TPE). 6.

Common examples are polypropylene (PP), nylon (PA), polyketone (PK), and thermoplastic elastomers (TPE). 6.

Q 4 AN D FU LL Y EA R 2020 PE RF O RM AN CE $0.30 $0.52 Q4 2020 ORGANIC PERFORMANCE Sales $922 $997 +8% Operating Income EPS $58 $80 +38% +73% • Record 4th quarter sales, adjusted operating income and adjusted EPS performance • All segments delivered year-over-year sales and operating income growth, led by consumer and healthcare end markets • Clariant Masterbatch integration synergy capture ahead of schedule: $5 million realized in 2020 ($ in millions except EPS) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q4 2020 SEGMENT PERFORMANCE 10 Sales Operating Income $100 $100 $100 $922 $100 $100 $100 $997 Distribution CAI SEM Total 2019 2020 $178 $272 $490 $191 $305 $526 SEM Distribution CAI +8% +7% +7% +12% $5 $5 $5 $58 $5 $5 $5 $80 Avient CAI SEM Total $17 $19 $40 $18 $30 $58 Distribution SEM CAI +38% +45% +58% +6% (3) (3) (1) (2) (1) Total company sales include intercompany sales eliminations (2) Total company reflects adjusted operating income and includes corporate costs (3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 2020 HIGHLIGHTS 11 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 23%8% 21% 2006 2020PF Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 12 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 25 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Other 2 3 2 2 2 3 3 3 4 4 5 5 5 6 6 6 7 25 t (E xc l.

PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Substantial EPS growth from $0.13 to all-time high of $1.80 • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Specialty mix expands to 65% of Operating Income – strongest mix of earnings in history • Accelerating growth • Deliver consistent double digit annual EPS growth • Maintain >35% vitality index • Pursue strategic acquisitions that expand specialty offerings and geographic breadth • Invest and grow current and next generation talent PolyOne Corporation Page 5 Building & 10% Electrical & 11% 9% Distribution 28% PP&S 52% 69% 13% 7% Asia 2014 Revenues: $3.8 Billion End Markets 2014 Revenues: $3.8 Billion PolyOne At A Glance $13 $31 $46 $46 $87 $96 $122 $195 $242 2006 2007 2008 2009 2010 2011 2012 2013 2014 Specialty Operating Income ($M) PolyOne Corporation Page 6 Old PolyOne *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65% 69% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 Q1 2015 2020 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 80%+ Specialty OI $5M $46M $87M $195M $242M $60M Mix Shift Highlights Specialty Transformation Transformation 2020 Platinum Vision Platinum Vision PolyOne Corporation Page 7 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 8 -100% 0% 200% 300% 400% 500% 600% Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 '06 '07 '08 '09 '10 '11 '12 '13 '14 ‘06-‘14 Adjusted EPS CAGR = 40% Adjusted EPS Share Price vs. S&P 500 PolyOne Corporation Page 9 2006 Q1 2015 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 16.2% 20%+ Global Specialty Engineered Materials 1.1% 16.3% 20%+ Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14% Performance Products & Solutions 5.5% 6.5% 10 – 12% Distribution 2.6% 5.9% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 69% 80%+ 3) ROIC 5.0% 11.4% 15% 4) Adjusted EPS Growth N/A 22 Consecutive Quarters of EPS Growth Double Digit Expansion Proof of Performance & 2020 Goals PolyOne Corporation Page 10 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 6 9 7 3 5 12 5 3 2 8 4 2 4 3 1 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 14 8 18 12 22 74 Addressable Market ($ millions) $700 $600 $600 $1,900 PolyOne Corporation Page 14 60% 98% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q1 2015 Pension Funding** As of March 31, 2015 Debt Maturities & Pension Funding Net Debt / EBITDA* = 2.1x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2015 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2015 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased over 500k shares in Q1 2015  Repurchased 11.8 million shares since early 2013  8.2 million shares are available for repurchase under the current authorization PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? Platform operating income mix percentage 2005* 2006* 2007* 2008* 2009* 2010* 2011 2012 2013 2014 2015 Q1 Global Color, Additives and Inks $ 4.3 $ 8.9 $ 25.7 $ 28.1 $ 25.2 $ 37.7 $ 50.2 $ 75.3 $ 104.0 $ 124.9 $ 33.8 Global Engineered Materials 0.4 3.9 4.9 17.6 20.6 49.7 45.9 47.0 57.2 72.4 23.1 Designed Structures and - - - - - - - - 33.4 45.1 3.2 Platform $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 96.1 $ 122.3 $ 194.6 $ 242.4 $ 60.1 Performance Products and 75.7 64.2 65.8 31.3 33.1 54.0 27.7 38.8 56.0 63.1 11.5 Distribution 19.5 19.2 22.1 28.1 24.8 42.0 56.0 66.0 63.3 68.2 15.7 Joint ventures 91.9 102.9 34.8 28.6 25.5 18.9 5.0 - - - - Corporate and eliminations (51.5) 34.5 (73.3) (425.1) 7.9 (27.7) 18.2 (89.6) (82.4) (218.6) (17.2) Operating income (loss) GAAP $ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 203.0 $ 137.5 $ 231.5 $ 155.1 $ 70.1 Less: Corporate operating expense 51.5 (34.5) 73.3 425.1 (7.9) 27.7 (18.2) 89.6 82.4 218.6 17.2 Operating income excluding Corporate $ 191.8 $ 199.1 $ 153.3 $ 133.7 $ 129.2 $ 202.3 $ 184.8 $ 227.1 $ 313.9 $ 373.7 $ 87.3 platform operating mix percentage 2% 6% 20% 34% 35% 43% 52% 54% 62% 65% 69% * Historical results have not been restated for the Resin business divestiture or the related resegmentation.